Literature DB >> 28627412

Macrophages Regulate Unilateral Ureteral Obstruction-Induced Renal Lymphangiogenesis through C-C Motif Chemokine Receptor 2-Dependent Phosphatidylinositol 3-Kinase-AKT-Mechanistic Target of Rapamycin Signaling and Hypoxia-Inducible Factor-1α/Vascular Endothelial Growth Factor-C Expression.

Yan-Chao Guo1, Meng Zhang1, Fa-Xi Wang2, Guang-Chang Pei3, Fei Sun2, Ying Zhang3, Xiaoyu He2, Yi Wang2, Jia Song2, Feng-Ming Zhu3, Nuruliarizki S Pandupuspitasari2, Jing Liu2, Kun Huang4, Ping Yang2, Fei Xiong2, Shu Zhang2, Qilin Yu2, Ying Yao5, Cong-Yi Wang6.   

Abstract

Lymphangiogenesis occurs during renal fibrosis in patients with chronic kidney diseases and vascular endothelial growth factor (VEGF)-C is required for the formation of lymphatic vessels; however, the underlying mechanisms remain unclear. We demonstrate that macrophages can regulate unilateral ureteral obstruction (UUO)-induced renal lymphangiogenesis by expressing high levels of VEGF-C by C-C motif chemokine receptor 2 (CCR2)-mediated signaling. Mice deficient in Ccr2 manifested repressed lymphangiogenesis along with attenuated renal injury and fibrosis after UUO induction. The infiltrated macrophages after UUO induction generated a microenvironment in favor of lymphangiogenesis, which likely depended on Ccr2 expression. Mechanistic studies revealed that CCR2 is required for macrophages to activate phosphatidylinositol 3-kinase (PI3K)-AKT-mechanistic target of rapamycin (mTOR) signaling in response to its ligand monocyte chemoattractant protein 1 stimulation, whereas hypoxia-inducible factor (HIF)-1α is downstream of PI3K-AKT-mTOR signaling. HIF-1α directly bound to the VEGF-C promoter to drive its expression to enhance lymphangiogenesis. Collectively, we characterized a novel regulatory network in macrophages, in which CCR2 activates PI3K-AKT-mTOR signaling to mediate HIF-1α expression, which then drives VEGF-C expression to promote lymphangiogenesis.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28627412     DOI: 10.1016/j.ajpath.2017.04.007

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  16 in total

1.  VEGFR3 tyrosine kinase inhibition aggravates cisplatin nephrotoxicity.

Authors:  Laurence M Black; Elisa R Farrell; Daria Barwinska; Gunars Osis; Anna A Zmijewska; Amie M Traylor; Stephanie K Esman; Subhashini Bolisetty; Grace Whipple; Malgorzata M Kamocka; Seth Winfree; Daryll R Spangler; Shehnaz Khan; Abolfazl Zarjou; Tarek M El-Achkar; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2021-10-18

Review 2.  Beyond a Passive Conduit: Implications of Lymphatic Biology for Kidney Diseases.

Authors:  Daniyal J Jafree; David A Long
Journal:  J Am Soc Nephrol       Date:  2020-04-15       Impact factor: 10.121

3.  Emerging roles for lymphatics in acute kidney injury: Beneficial or maleficent?

Authors:  Heidi A Creed; Joseph M Rutkowski
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-19

4.  Kdm2a deficiency in macrophages enhances thermogenesis to protect mice against HFD-induced obesity by enhancing H3K36me2 at the Pparg locus.

Authors:  Longmin Chen; Jing Zhang; Yuan Zou; Faxi Wang; Jingyi Li; Fei Sun; Xi Luo; Meng Zhang; Yanchao Guo; Qilin Yu; Ping Yang; Qing Zhou; Zhishui Chen; Huilan Zhang; Quan Gong; Jiajun Zhao; Decio L Eizirik; Zhiguang Zhou; Fei Xiong; Shu Zhang; Cong-Yi Wang
Journal:  Cell Death Differ       Date:  2021-01-18       Impact factor: 15.828

Review 5.  The lymphatics in kidney health and disease.

Authors:  Michael D Donnan; Yael Kenig-Kozlovsky; Susan E Quaggin
Journal:  Nat Rev Nephrol       Date:  2021-06-22       Impact factor: 42.439

6.  Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1.

Authors:  Vivian Adamski; Kirsten Hattermann; Carolin Kubelt; Gesa Cohrs; Ralph Lucius; Michael Synowitz; Susanne Sebens; Janka Held-Feindt
Journal:  Oncogene       Date:  2020-04-28       Impact factor: 9.867

7.  Lymphangiogenesis in kidney and lymph node mediates renal inflammation and fibrosis.

Authors:  Guangchang Pei; Ying Yao; Qian Yang; Meng Wang; Yuxi Wang; Jianliang Wu; Pengge Wang; Yueqiang Li; Fengming Zhu; Juan Yang; Ying Zhang; Weiqi Yang; Xuan Deng; Zhi Zhao; Han Zhu; Shuwang Ge; Min Han; Rui Zeng; Gang Xu
Journal:  Sci Adv       Date:  2019-06-26       Impact factor: 14.136

8.  VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness.

Authors:  Papa Diogop Ndiaye; Maeva Dufies; Sandy Giuliano; Laetitia Douguet; Renaud Grépin; Jérôme Durivault; Philippe Lenormand; Natacha Glisse; Janita Mintcheva; Valérie Vouret-Craviari; Baharia Mograbi; Maud Wurmser; Damien Ambrosetti; Nathalie Rioux-Leclercq; Pascal Maire; Gilles Pagès
Journal:  Theranostics       Date:  2019-01-21       Impact factor: 11.556

9.  Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease.

Authors:  Abolfazl Zarjou; Laurence M Black; Subhashini Bolisetty; Amie M Traylor; Sarah A Bowhay; Ming-Zhi Zhang; Raymond C Harris; Anupam Agarwal
Journal:  Lab Invest       Date:  2019-04-24       Impact factor: 5.662

10.  IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages.

Authors:  Li-Zong Rao; Yi Wang; Lei Zhang; Guorao Wu; Lu Zhang; Fa-Xi Wang; Long-Min Chen; Fei Sun; Song Jia; Shu Zhang; Qilin Yu; Jiang-Hong Wei; Hui-Ren Lei; Ting Yuan; Jinxiu Li; Xingxu Huang; Bin Cheng; Jianping Zhao; Yongjian Xu; Bi-Wen Mo; Cong-Yi Wang; Huilan Zhang
Journal:  Cell Death Differ       Date:  2020-11-03       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.